AI assistant
Glenmark Pharmaceuticals ltd — Call Transcript 2024
Nov 21, 2024
62608_rns_2024-11-21_e97dabe5-3d71-4656-a7cf-c9f4fc3cf036.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [33 x 32] intentionally omitted <==
==> picture [148 x 45] intentionally omitted <==
November 21, 2024
To, To, Dy. General Manager The Manager – Listing, Department of Corporate Services, National Stock Exchange of India Ltd., BSE Ltd., Plot No. C/1, G Block, P. J. Towers, Dalal Street, Bandra Kurla Complex, Fort, Mumbai – 400 001 Bandra (E), Mumbai – 400 051
Ref: Scrip Code: 532296
Ref: Scrip Name: GLENMARK
Dear Sirs,
Sub: Transcript of the Earnings Call
Further to our letter dated 6th November, 2024 and pursuant to Regulation 30(6) read with Part A of Schedule III of SEBI (LODR), Regulations 2015, the transcript of the Earnings call held on Monday, November 18, 2024 for the second quarter ended September 30, 2024 has been uploaded on the Company’s website at https://glenmark.b- cdn.net/gpl_pdfs/investors/reports_presentations/earning_concall/GlenmarkPharma Earnings-18%20Nov-2024.pdf.
Request you to kindly take the same on record.
Thanking you.
Yours faithfully,
For Glenmark Pharmaceuticals Limited
HARISH Digitally signed by HARISH VINAYAK VINAYAK KUBER Date: 2024.11.21 KUBER 17:09:40 +05'30'
Harish Kuber
Company Secretary & Compliance Officer
Tel: 4018 9999 / 4018 9879 Fax: 4018 9986 (Legal & Secretarial Dept.)
Glenmark Pharmaceuticals Ltd. Glenmark House, B D Sawant Marg, Andheri (E), Mumbai 400 099 T: 91 22 4018 9999 F: 91 22 4018 9988 CIN No: L24299MH1977PLC019982 W: www.glenmarkpharma.com Registered office: B/2, Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai 400 026 E: [email protected]